Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$4.40
+0.200 (+4.76%)
At Close: May 08, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0858 $8.83 Wednesday, 8th May 2024 ATXI stock ended at $4.40. This is 4.76% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 13.73% from a day low at $4.15 to a day high of $4.72.
90 days $0.0858 $8.83
52 weeks $0.0858 $8.83

Historical Avenue Therapeutics, Inc. prices

Date Open High Low Close Volume
Oct 03, 2023 $0.640 $0.702 $0.690 $0.701 70 070
Oct 02, 2023 $0.630 $0.707 $0.630 $0.690 82 918
Sep 29, 2023 $0.650 $0.713 $0.650 $0.707 24 628
Sep 28, 2023 $0.700 $0.700 $0.666 $0.671 38 293
Sep 27, 2023 $0.696 $0.710 $0.670 $0.693 35 926
Sep 26, 2023 $0.567 $0.720 $0.562 $0.680 385 857
Sep 25, 2023 $0.553 $0.650 $0.541 $0.562 50 323
Sep 22, 2023 $0.605 $0.620 $0.539 $0.570 107 760
Sep 21, 2023 $0.730 $0.730 $0.611 $0.614 102 892
Sep 20, 2023 $0.770 $0.780 $0.690 $0.710 91 208
Sep 19, 2023 $0.760 $0.80 $0.751 $0.780 66 957
Sep 18, 2023 $0.82 $0.86 $0.780 $0.80 29 789
Sep 15, 2023 $0.82 $0.85 $0.779 $0.83 107 765
Sep 14, 2023 $0.769 $0.84 $0.769 $0.83 106 603
Sep 13, 2023 $0.781 $0.84 $0.781 $0.785 75 327
Sep 12, 2023 $0.760 $0.82 $0.760 $0.795 107 923
Sep 11, 2023 $0.770 $0.770 $0.720 $0.720 8 379
Sep 08, 2023 $0.701 $0.751 $0.703 $0.750 16 560
Sep 07, 2023 $0.730 $0.769 $0.712 $0.734 35 170
Sep 06, 2023 $0.740 $0.765 $0.730 $0.748 25 504
Sep 05, 2023 $0.80 $0.80 $0.730 $0.738 54 343
Sep 01, 2023 $0.790 $0.80 $0.780 $0.789 14 870
Aug 31, 2023 $0.82 $0.82 $0.770 $0.776 65 245
Aug 30, 2023 $0.82 $0.85 $0.80 $0.84 30 962
Aug 29, 2023 $0.83 $0.89 $0.83 $0.87 26 386
Click to get the best stock tips daily for free!

About Avenue Therapeutics, Inc.

Avenue Therapeutics. Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.... ATXI Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT